Impacts of Hyperandrogenism in Women with Polycystic Ovary Syndrome: A Literature Review

    Isabela Rodrigues da Silva, Shi Juin Lam, Anna Vitória de Matos Carneiro, Polyana Aparecida Bisinoto, Rubia de Souza Olivo, Adriely Portela Souza Lima, Rafael Leituga de Carvalho Cavalcante, Marina Farias Lira, Júlia Rocha Morão, Yasmim de Paula Deitos, Livia Cararo Nogueira, Neidejany de Assunção do Sacramento
    Image
    Studysummary This review discusses the pathophysiological impacts of hyperandrogenism in women with PCOS and reports no new clinical results; the authors highlight lifestyle changes as a primary management strategy.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The literature review discusses the impacts of hyperandrogenism in women with polycystic ovary syndrome (PCOS). The review was based on 11 studies selected from 370 articles found in the Scielo and Pubmed databases. The study found that clinical manifestations of PCOS, such as ovulatory disorders, infertility, hirsutism, acne, and androgenic alopecia, are pathophysiological impacts of androgenism. Hyperinsulinemia, a condition present in women diagnosed with PCOS, contributes to androgen-dependent anovulation. Irregular menstrual cycles are indicative of anovulation, which is considered favorable for infertility associated with PCOS. The review concludes that due to the significant influence of the patient's physical conditions, therapies aimed at lifestyle changes are the first management of such a situation.
    Discuss this study in the Community →